CTT Pharmaceutical Holdings, Inc. (NASDAQ:CTTH) | WebDisclosure

Basculer en Français

10212	Companies
210367	Keywords
140389	Articles
111485	Press releases

Headlines Articles Press releases CTT Pharmaceutical Holdings, Inc.

Home
Companies
CTT Pharmaceutical Holdings, Inc.

PRESS RELEASE

published on 02/25/2025 at 13:15, 1 year 1 month ago

CTT Pharma Gives Update On U.S. and European Patents
CTT Pharmaceutical Holdings, Inc. receives intention to grant additional claims for diabetes drug patent from European Patent Office and plans to utilize micelle technology for enhanced drug delivery. Seeking opportunities for pharmaceutical companies

Drug Delivery European Patent Office Micelle Technology CTT Pharmaceutical Holdings Diabetes Drug Patent
BRIEF

published on 02/12/2025 at 13:20, 1 year 2 months ago

CTT Pharma progresse dans la subvention NSF pour les bandelettes de nicotine

Innovation CTT Pharma Bandelettes De Nicotine Subvention NSF Épidémie De Tabagisme
BRIEF

published on 02/12/2025 at 13:20, 1 year 2 months ago

CTT Pharma Progresses in NSF Grant for Nicotine Strips

Innovation CTT Pharma Nicotine Strips NSF Grant Tobacco Epidemic
PRESS RELEASE

published on 02/12/2025 at 13:15, 1 year 2 months ago

CTT Pharma Gives Update On NSF Grant
CTT Pharmaceutical Holdings, Inc. (OTC:CTTH) advances to the next round of NSF grant program with their patented fast dissolving nicotine strips, aiming to combat the global tobacco epidemic

Public Health Tobacco Epidemic CTT Pharmaceutical Holdings NSF Grant Program Fast Dissolving Nicotine Strips
BRIEF

published on 02/05/2025 at 13:20, 1 year 2 months ago

CTT Pharmaceuticals Welcomes Dr. Katherine Cole as Independent Director

Independent Director Biomedical Science CTT Pharmaceuticals Katherine Cole NIH Experience
BRIEF

published on 02/05/2025 at 13:20, 1 year 2 months ago

CTT Pharmaceuticals accueille le Dr Katherine Cole au poste de directrice indépendante

Administrateur Indépendant Katherine Cole CTT Pharmaceutique Expérience Du NIH Sciences Biomédicales
PRESS RELEASE

published on 02/05/2025 at 13:15, 1 year 2 months ago

CTT Pharma Adds Independent Director With NIH/NSF Experience
CTT Pharmaceuticals Holdings, Inc. welcomes Dr. Katherine Cole, a highly accomplished professional with a Ph.D. in Pathology, as an Independent Director. Dr. Cole's extensive experience in cancer research and academia brings valuable insight to CTT

Bioavailability Drug Delivery CTT Pharmaceuticals Dr. Katherine Cole Ph.D. In Pathology
BRIEF

published on 02/03/2025 at 13:20, 1 year 2 months ago

CTT Pharma réduit le nombre d'actions autorisées

Actionnaires Structure Du Capital Réduction Des Parts CTT Pharma Liste De Mise À Niveau OTCQB
BRIEF

published on 02/03/2025 at 13:20, 1 year 2 months ago

CTT Pharma Reduces Authorized Share Count

Shareholders Capital Structure Share Reduction CTT Pharma OTCQB Uplist
PRESS RELEASE

published on 02/03/2025 at 13:15, 1 year 2 months ago

CTT Pharma Reduces Authorized Share Count
CTT Pharmaceuticals Holdings, Inc. reduces authorized share count by 150 million shares, demonstrating commitment to optimizing capital structure and value to shareholders. Company to uplist to OTCQB

OTCQB Capital Structure CTT Pharmaceuticals Authorized Share Count Micelle Technology

Accesswire

Published on 04/14/2026 at 17:00, 58 minutes ago

Intention to List on the Namibia Securities Exchange
Published on 04/14/2026 at 15:05, 2 hours 53 minutes ago

Karbon-X Expands Canadian Compliance Offering as Regulatory Deadlines Approach Across Federal and Provincial Carbon Markets
Published on 04/14/2026 at 15:00, 2 hours 58 minutes ago

Datavault AI and AgSensor Solutions Announce Consulting Partnership to Tokenize High-Value Agricultural Data Assets
Published on 04/14/2026 at 14:55, 3 hours 3 minutes ago

BEACN Introduces Voice-First Headset as It Expands Its Creator Audio Platform
Published on 04/14/2026 at 14:30, 3 hours 28 minutes ago

Goldcliff Extends Kettle Valley Drill Permit to 2028 and Completes Trench Program Advancing North Cliff Zone Targets

View all ACCESSWIRE

EQS Group

Published on 04/14/2026 at 17:45, 13 minutes ago

VAZIVA SA: Précisions sur l’émission d’obligations convertibles en actions nouvelles (OCA) de 8 M€ à un taux de 7,0% par an et à maturité de 3 ans
Published on 04/14/2026 at 17:40, 18 minutes ago

Carvolix : Nombre d’actions composant le capital social et nombre total de droits de vote au 31.03.26.
Published on 04/14/2026 at 17:24, 33 minutes ago

EQS-Adhoc: tick Trading Software AG raises forecast for the current business year 2025/2026
Published on 04/14/2026 at 17:09, 49 minutes ago

Annual General Meeting V-ZUG: Shareholders approve all proposals
Published on 04/14/2026 at 17:03, 55 minutes ago

Kickoff for automated drone defense from Brandenburg: Joint venture ONBERG begins operations

Les Echos

Published on 04/14/2026 at 17:40, 18 minutes ago

Collaboration entre Mersen et Terra Innovatum
Published on 04/14/2026 at 17:40, 18 minutes ago

Collaboration between Terra Innovatum and Mersen
Published on 04/14/2026 at 17:00, 58 minutes ago

FinanceWire Introduces Certidox to Enable Verifiable Press Releases as Fake Content Becomes Indistinguishable from Reality
Published on 04/14/2026 at 17:00, 58 minutes ago

FinanceWire intègre Certidox pour permettre la vérification des communiqués de presse, alors que les contenus falsifiés deviennent impossibles à distinguer de la réalité
Published on 04/14/2026 at 08:30, 9 hours 28 minutes ago

ALPOU - Groupe POULAILLON - Projet offre publique d'achat obligatoire

View all LES ECHOS COMFI WIRE